Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Call For Papers

Special Issue on Lung Cancer


Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC).


In this special issue, we intend to invite front-line researchers and authors to submit original research and review articles on lung cancer. Potential topics include, but are not limited to:

  • Causes, diagnosis, treatment and prognosis
  • Lung cancer surgery and lung transplantation
  • Chemotherapy, radiation therapy, immunotherapy and drug use
  • Lung cancer stem cells
  • Non-small-cell lung cancer and lung adenocarcinoma
  • EGFR mutations
  • Gene therapy for lung cancer
  • Apoptosis and DNA repair deficiency
  • Smoking and lung cancer
  • Biomarkers in lung cancer
  • Metastasis and lung cancer
  • Lung cancer screening and prevention

Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal’s Paper Submission System.


Please kindly notice that the “Special Issue” under your manuscript title is supposed to be specified and the research field “Special Issue – Lung Cancer should be chosen during your submission.


According to the following timetable:


Submission Deadline

June 14th, 2019

Publication Date

July 2019


For publishing inquiries, please feel free to contact the Editorial Assistant at submission.entrance1@scirp.org


JCT Editorial Office

jct@scirp.org


Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top